Dabigatran for the treatment and secondary prevention of venous thromboembolism: a cost-effectiveness analysis for the Netherlands - Stevanović, J; de Jong, L A; Kappelhoff, B S; Dvortsin, E P; Voorhaar, M; Postma, M J (PLoS One, 2016)